US researchers have discovered that an already approved arthritis drug may offer a cheap, low-dose treatment for the amoebic infections that cause dysentery in humans worldwide. So far they have only tested the drug in lab and animal studies, but they have applied for approval to start clinical trials to test it as a treatment for both amebiasis and the parasite Giardia in humans. The researchers, from University of California - San Diego (UCSD), and University of California - San Francisco (UCSF), write about their findings in the 20 May online issue of Nature Medicine...
More...
More...